# Harmony Baby Nutrition

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/harmony-baby-nutrition

- Industry: Food
- Headquarters: Boston, US
- Website: www.harmonybabynutrition.com
- Latest round: Seed (Jan 14, 2021)
- Investors on record: 2

## About

Milk Care Co., Inc. specializes in developing hypoallergenic infant formula that closely mimics the nutritional composition of human milk, catering to health-conscious parents seeking high-quality nutrition options for their infants.Founded in 2018, Milk Care Co., Inc. is headquartered in Boston, US. The company focuses on providing innovative infant nutritional solutions and has completed two investment deals to date. In December 2025, Harmony Baby Nutrition raised BRL 31.8 million in grant funding from FINEP-BNDES. Del Afonso serves as both the founder and CEO, bringing his expertise in nutrition and product development to the company.Harmony Baby Nutrition specializes in producing hypoallergenic infant formula that closely replicates the composition of human milk. Their flagship product contains over 50% components found in human milk and is enriched with human milk oligosaccharides (HMOs) to support immunity and gut health. The company targets health-conscious parents in North America and Europe, offering an alternative to traditional formulas that promotes better digestion and simplifies the feeding process for infants and caregivers.Harmony Baby Nutrition generates revenue primarily through direct-to-consumer sales of its infant formula via their website. The pricing model incentivizes bulk purchases to enhance customer loyalty and repeat business among parents who value the unique formulation of the product. This approach positions the company effectively within the competitive infant nutrition market.In January 2021, Milk Care Co., Inc. raised USD 80,000 in a Seed funding round led by SOSV, with participation from IndieBio. The company plans to utilize this funding to develop new product offerings and expand into additional markets. Specific geographic regions targeted for expansion include greater penetration in Europe and Canada, with plans to introduce new formulations tailored to these markets by 2023.

## Funding rounds

- Seed, Jan 14, 2021 — SOSV, IndieBio

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- IndieBio (https://capitalatlas.ai/funds/indiebio) — Seed